269 related articles for article (PubMed ID: 20668064)
1. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
[TBL] [Abstract][Full Text] [Related]
2. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
3. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.
Crescenzi E; Raia Z; Pacifico F; Mellone S; Moscato F; Palumbo G; Leonardi A
J Biol Chem; 2013 Jun; 288(23):16212-16224. PubMed ID: 23612976
[TBL] [Abstract][Full Text] [Related]
5. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
[TBL] [Abstract][Full Text] [Related]
6. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.
Lu X; Nguyen TA; Moon SH; Darlington Y; Sommer M; Donehower LA
Cancer Metastasis Rev; 2008 Jun; 27(2):123-35. PubMed ID: 18265945
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response.
Zhang X; Lin L; Guo H; Yang J; Jones SN; Jochemsen A; Lu X
Cancer Res; 2009 Oct; 69(20):7960-8. PubMed ID: 19808970
[TBL] [Abstract][Full Text] [Related]
8. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung.
Rahman M; Lovat F; Romano G; Calore F; Acunzo M; Bell EH; Nana-Sinkam P
J Biol Chem; 2014 Sep; 289(38):26406-26416. PubMed ID: 25092292
[TBL] [Abstract][Full Text] [Related]
9. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.
Nguyen TA; Slattery SD; Moon SH; Darlington YF; Lu X; Donehower LA
DNA Repair (Amst); 2010 Jul; 9(7):813-23. PubMed ID: 20451471
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
12. Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response.
Cha H; Lowe JM; Li H; Lee JS; Belova GI; Bulavin DV; Fornace AJ
Cancer Res; 2010 May; 70(10):4112-22. PubMed ID: 20460517
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.
Macurek L; Benada J; Müllers E; Halim VA; Krejčíková K; Burdová K; Pecháčková S; Hodný Z; Lindqvist A; Medema RH; Bartek J
Cell Cycle; 2013 Jan; 12(2):251-62. PubMed ID: 23255129
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
15. DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.
Brazina J; Svadlenka J; Macurek L; Andera L; Hodny Z; Bartek J; Hanzlikova H
Cell Cycle; 2015; 14(3):375-87. PubMed ID: 25659035
[TBL] [Abstract][Full Text] [Related]
16. A novel assay for screening WIP1 phosphatase substrates in nuclear extracts.
Storchova R; Burdova K; Palek M; Medema RH; Macurek L
FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis.
Yang YQ; Zheng YH; Zhang CT; Liang WW; Wang SY; Wang XD; Wang Y; Wang TH; Jiang HQ; Feng HL
Neurobiol Dis; 2020 Feb; 134():104648. PubMed ID: 31676238
[TBL] [Abstract][Full Text] [Related]
18. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
Lu X; Nguyen TA; Donehower LA
Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
[TBL] [Abstract][Full Text] [Related]
19. Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
Xia Y; Ongusaha P; Lee SW; Liou YC
J Biol Chem; 2009 Jun; 284(26):17428-37. PubMed ID: 19395378
[TBL] [Abstract][Full Text] [Related]
20. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation.
Choi DW; Na W; Kabir MH; Yi E; Kwon S; Yeom J; Ahn JW; Choi HH; Lee Y; Seo KW; Shin MK; Park SH; Yoo HY; Isono K; Koseki H; Kim ST; Lee C; Kwon YK; Choi CY
Mol Cell; 2013 Aug; 51(3):374-85. PubMed ID: 23871434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
